Pharmacists in Hellertown, Pennsylvania


13 Pharmacists found in Hellertown
male pharmacist

Andrew Dum, RPH


Pharmacist
1880 Leithsville Rd, Hellertown, PA 18055
610-838-3007     610-838-5161

female pharmacist

Asma Moustafa Mohamed Hassan


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
1332 Main St, Hellertown, PA 18055
610-838-5611    

male pharmacist

Carl Martin, RPH


Pharmacist
1322 Main St, Hellertown, PA 18055
610-838-5611    



female pharmacist

Dr. Charlene Noto-morgan, PHARM D


Pharmacist
110 Main St, Hellertown, PA 18055
610-838-7371    

male pharmacist

Dr. Frank Palumbo, PHARMD


Pharmacist
2566 Kings Mill Rd, Hellertown, PA 18055
610-838-0751    

male pharmacist

Mr. Howard Clinton Cook Jr., R.PH., BCNSP, FASHP


Pharmacist
654 Main St, Hellertown, PA 18055
610-838-0411    

female pharmacist

Jamie Casterline


Pharmacist
1332 Main St, Hellertown, PA 18055
610-838-5611    

male pharmacist

Jeremy A Nolt


Pharmacist
1880 Leithsville Rd, Hellertown, PA 18055
610-838-3007     844-411-6605

female pharmacist

Megan Kern


Pharmacist
110 Main St, Hellertown, PA 18055
610-838-7371    

male pharmacist

Michael William Brown, RPH


Pharmacist
110 Main St, Hellertown, PA 18055
610-838-7371    

male pharmacist

Mr. Mykola John Salata, PHARMACIST


Pharmacist
654 Main St, Hellertown, PA 18055
610-838-0411     610-838-6780

female pharmacist

Rebecca Broadt


Pharmacist
1880 Leithsville Rd, Hellertown, PA 18055
610-838-3007    

male pharmacist

Mr. William Donald Popp, RPH


Pharmacist
110 Main St, Hellertown, PA 18055
610-838-7371     610-838-0141


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.